Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalDrug Design, Development and Therapy
DOIs
StatePublished - 2019

Cite this

@article{c0628abca1c545d0a4dd1189f80a9735,
title = "Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling",
author = "Hong Liu",
year = "2019",
doi = "DOI: 10.2147/DDDT.S219533",
language = "English (US)",
journal = "Drug Design, Development and Therapy",
issn = "1177-8881",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling

AU - Liu, Hong

PY - 2019

Y1 - 2019

U2 - DOI: 10.2147/DDDT.S219533

DO - DOI: 10.2147/DDDT.S219533

M3 - Article

JO - Drug Design, Development and Therapy

JF - Drug Design, Development and Therapy

SN - 1177-8881

ER -